Cancer Screening

Transgender women are significantly less likely than cisgender men to undergo prostate cancer screening, findings suggest, and the principal driver of the disparity appears to be whether physicians recommended testing — not access to care.

As a young child, Coral Olazagasti, MD, participated in church community service with her mother in Puerto Rico. Fast forward years later where she continued to feed that passion by joining community medical mission trips in Guatemala and Haiti.

Invasive procedures aimed at clearing up imaging abnormalities found on lung cancer screening scans occurred infrequently, according to results published in CHEST.

Considering conflicting clinical guidelines, primary care providers should focus on individualized decision-making when deciding if and when a patient should be screened for breast cancer, according to experts.

Black men should consider early PSA screening for prostate cancer, ideally starting at age 40, according to recommendations presented at ASCO Genitourinary Cancers Symposium.

Colorectal cancer incidence has increased since 1988 among men but not women younger than 50 years, suggesting that patient sex should be factored in when determining screening age, data from an Austrian study showed.

Vaccination against HPV and routine screening are the primary methods for cervical cancer prevention, and the convenience of at-home HPV tests may increase screening and lower cervical cancer prevalence in the U.S.

For individuals with an incidentally detected lung nodule who are ineligible for lung cancer screening based on age, a lung nodule program may catch lung cancer early, according to results published in Journal of Thoracic Oncology.

Among patients with negative fecal immunochemical tests, those with values in the upper range demonstrated higher risk for advanced neoplasia vs. those in the lower range, according to data in Annals of Internal Medicine.

A risk-advancement period approach using sex and polygenic risk score helped identify starting ages for colorectal cancer screening, with men reaching an equivalent risk for CRC occurrence and mortality at a younger age than women.